arrow
L

Lorena Lorefice

binaghi hospital
H指数:30
被引数:3,127

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long‐Term Disease Control Following Completion of Cladribine Treatment in Multiple Sclerosis: Extended Follow‐Up of the CladStop Cohort

多发性硬化患者完成克拉屈滨治疗后长期疾病控制:<scp>CladStop</scp>队列的扩展随访

2026-10-300
OAAI
The impact of multiple sclerosis on social determinants of health: Results from the SocialMS study

多发性硬化对社会决定性健康因素的影响:SocialMS研究的结果

2026-07-010
OAAI
Salivary Proteomics Reveals Disease- and Therapy-Associated Molecular Patterns in Relapsing-Remitting Multiple Sclerosis

唾液蛋白质组学揭示复发缓解型多发性硬化症中与疾病和治疗相关的分子模式

2026-01-010
OA
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies
2025-02-011
PRE
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy

怀孕期间暴露于富马酸二甲酯的多发性硬化症妇女的意大利多中心队列的母婴结局

2024-09-120
PRE
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination

多发性硬化症的疾病修饰疗法对免疫细胞和新型冠状病毒肺炎疫苗接种反应的影响

2024-07-151
OAAI
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis

新型冠状病毒肺炎对多发性硬化妇女妊娠和胎儿结局的影响

2024-03-081
OA
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis
2024-01-013
OAAI
Sars-CoV2 infection in pregnant women with multiple sclerosis

多发性硬化症孕妇的Sars-CoV2感染

2023-05-261
OA
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs

用高效dmt治疗的多发性硬化症患者接受三种mRNA疫苗剂量后的症状性新型冠状病毒肺炎过程和结局

2023-05-117
OA